Following our previous study [6], linking RASSF1 methylation with PCa aggressiveness, and showing a good diagnostic power of the 3-gene methylation test, we tested the diagnostic potential of this noninvasive tool in the settings of the PCa risk change after RP. The gene discussed is RASSF1; the disease is posterior cortical atrophy.